Clinical Trial: REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cardiovascular Disease
Study Type: INTERVENTIONAL
Official Title: The Cardiovascular Safety and Efficacy of Cagrilintide 2.4 mg s.c. in Combination With Semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) Once-weekly in Participants With Established Cardiova
Brief Summary:
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardiovascular disease.Participants will either get CagriSema or a dummy medicine (also called "placebo") which has no effect on the body.Which treatment participants will get will be decided by chance.Participant's chance of getting CagriSema or placebo is the same.Participants will inject the study medicine once a week.The study medicine will be injected briefly…
Read more